Related references
Note: Only part of the references are listed.Atypical hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: Clinically differentiating the thrombotic microangiopathies
Spero R. Cataland et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2013)
ADAMTS-13 may not predict disease or outcome in patients with Thrombotic Thrombocytopenic Purpura
G. Rock et al.
THROMBOSIS RESEARCH (2013)
Efficacy of rituximab in acute refractory or chronic relapsing non-familial idiopathic thrombotic thrombocytopenic purpura: a systematic review with pooled data analysis
Nay M. Tun et al.
JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2012)
A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura
Marie Scully et al.
BLOOD (2011)
Atypical hemolytic uremic syndrome
Chantal Loirat et al.
ORPHANET JOURNAL OF RARE DISEASES (2011)
Survival and relapse in patients with thrombotic thrombocytopenic purpura
Johanna A. Kremer Hovinga et al.
BLOOD (2010)
Different clinical severity of first episodes and recurrences of thrombotic thrombocytopenic purpura
Luca A. Lotta et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience
Paul Coppo et al.
PLOS ONE (2010)
Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab
Domenica Caramazza et al.
TRANSFUSION (2010)
Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: Results of a Spanish multicenter study
Javier de la Rubia et al.
TRANSFUSION AND APHERESIS SCIENCE (2010)
Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: A report of 13 cases and review of the literature
Huichung T. Ling et al.
AMERICAN JOURNAL OF HEMATOLOGY (2009)
Rituximab for refractory and or relapsing thrombotic thrombocytopenic purpura related to immune-mediated severe ADAMTS13-deficiency: a report of four cases and a systematic review of the literature
Mischelle A. Elliott et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
A Canadian phase II study evaluating the efficacy of rituximab in the management of patients with relapsed/refractory thrombotic thrombocytopenic purpura
Stephen R. Foley et al.
KIDNEY INTERNATIONAL (2009)
Treating TTP/HUS with plasma exchange: a single centre's 25-year experience
Brian R. Forzley et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features
Marie Scully et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
The Oklahoma thrombotic thrombocytopenic purpura-hemolytic uremic syndrome registry: The swiss connection
James N. George et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2008)
Rituximab as an Adjunct to Plasma Exchange in TTP: A Report of 12 Cases and Review of Literature
Sushama Jasti et al.
JOURNAL OF CLINICAL APHERESIS (2008)
Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS): a 24-year clinical experience with 178 patients
Mark Levandovsky et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2008)
Does hemolytic uremic syndrome differ from thrombotic thrombocytopenic purpura?
Fadi Fakhouri et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2007)
Thrombotic thrombocytopenic purpura
JN George
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Relapse of thrombotic thrombocytopenic purpura: Is it a continuum of disease?
MS Willis et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2005)
Pathogenesis of thrombotic thrombocytopenic purpura: ADAMTS13 deficiency and beyond
ECY Lian
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2005)
Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement
P Coppo et al.
MEDICINE (2004)
Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura
HM Tsai
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Remission of chronic thrombotic thrombocytopenic purpura after treatment with cyclophosphamide and rituximab
XL Zheng et al.
ANNALS OF INTERNAL MEDICINE (2003)
Mechanisms of disease - Thrombotic microangiopathies
JL Moake
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders:: a severely deficient activity is specific for thrombotic thrombocytopenic purpura
V Bianchi et al.
BLOOD (2002)
The revised CONSORT statement for reporting randomized trials: Explanation and elaboration
DG Altman et al.
ANNALS OF INTERNAL MEDICINE (2001)
Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS): Treatment outcome, relapses, prognostic factors. A single-center experience of 48 cases
J Dervenoulas et al.
ANNALS OF HEMATOLOGY (2000)
Share Paper
